Examkin

Question

Difficulty: Very hardClinical Preventive Services and Screening

A 54-year-old woman comes to the primary care clinic for an annual health maintenance examination. She has a history of a heart transplant 3 years ago for nonischemic cardiomyopathy and is currently maintained on a regimen of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Her last menstrual period occurred at age 50. During the review of systems, she mentions noticing a small amount of pinkish vaginal spotting on her toilet tissue yesterday, which she assumes is due to vaginal dryness. She has never smoked and consumes alcohol socially. Her last screening mammogram was at age 52, and her last colonoscopy was at age 48; both were normal. She has not received any vaccinations since prior to her transplant. Vital signs are within normal limits. Physical examination reveals a well-healed median sternotomy scar but is otherwise unremarkable. Which of the following combinations represents the most appropriate management plan for this patient today?

  1. Endometrial biopsy, screening mammography, and administration of the recombinant zoster vaccineAnswer
  2. B
    Reassurance for likely atrophic vaginitis, screening mammography, and administration of the recombinant zoster vaccine
  3. C
    Endometrial biopsy, screening mammography, and administration of the live-attenuated varicella vaccine
  4. D
    Prescription of topical vaginal estrogen, repeat colonoscopy, and administration of the 20-valent pneumococcal conjugate vaccine
  5. E
    Transvaginal ultrasound, screening breast magnetic resonance imaging (MRI), and administration of the live-attenuated influenza vaccine

Answer

The most appropriate management plan includes an endometrial biopsy to evaluate the postmenopausal bleeding, a screening mammogram, and the administration of the recombinant zoster vaccine.
This patient requires three distinct interventions. First, any postmenopausal bleeding (even a single episode of spotting) requires evaluation to rule out endometrial cancer, typically beginning with an endometrial biopsy. Second, she is due for breast cancer screening, as mammography is recommended every two years for average-risk women. Third, because she is on maintenance immunosuppression for a heart transplant, she is at high risk for herpes zoster; the non-live recombinant zoster vaccine is specifically recommended for all immunosuppressed adults over age 19. Live vaccines must be strictly avoided.

Step-by-Step Solution

1
Address the patient's acute symptom of postmenopausal bleeding (PMB).
Determine that an endometrial biopsy (or transvaginal ultrasound) is mandatory.
Any vaginal bleeding in a postmenopausal woman must be thoroughly evaluated to rule out endometrial hyperplasia or carcinoma; it cannot be dismissed as simple atrophic vaginitis based on history alone.
2
Evaluate the patient's breast cancer screening status.
Determine that a screening mammogram is due.
Current USPSTF guidelines recommend biennial (every 2 years) screening mammography. Since her last mammogram was at age 52, she is due for her next scan at age 54.
3
Evaluate the patient's colorectal cancer screening status.
Determine that a colonoscopy is not currently due.
For an average-risk patient with a previously normal colonoscopy, the recommended screening interval is 10 years. Her last colonoscopy was at age 48, meaning she is not due until age 58.
4
Determine the appropriate immunizations for a solid organ transplant recipient on immunosuppressive therapy.
Identify that the recombinant zoster vaccine is indicated, while live vaccines are contraindicated.
The ACIP recommends the non-live recombinant zoster vaccine for all adults aged 19 years and older who are immunodeficient or immunosuppressed. Live vaccines (e.g., varicella, intranasal influenza) carry a high risk of disseminated infection in patients taking tacrolimus and mycophenolate.

Key Concept

Comprehensive preventive care in immunosuppressed patients requires tailoring cancer screening intervals (e.g., biennial mammography, 10-year colonoscopy) and strictly adhering to immunization safety (avoiding live vaccines, utilizing non-live recombinant vaccines), while remaining vigilant for diagnostic red flags like postmenopausal bleeding.
Estimated Time:2m 0s
Rate this question

Topics

Clinical Preventive Services and Screening

More questions from this topic